I thought it was interesting that one of the presentation slides mentioned developing LymPro as a "homebrew" test. Is that wording new? If so, do you think that means they're leaning toward going it alone (without BD or another partner)?
bio_guy: I posted an article about the "Pathway to Commercialization for in vitro diagnostics in the US." There are 3 times of diagnostics, but the most common is "Laboratory-Developed Test" (LDT) This is the class which LymPro falls into. After it completes the 6 month "Clinical Laboratory Improvement Act" (CLIA) certification, it can be commercialized immediately. It doesn't have to wait for FDA approval. I think the "homebrew test" was mentioned in connection with what I just explained. It refers to it's class, not whether or not we have a big partner. The press release introducing Dr. Bier used the above terminology in how they will commercialize LymPro.